References in periodicals archive ?
AML is the most common form of adult acute leukemia, accounting for 80% of all diagnosed cases, with approximately 13,000 new cases diagnosed in the U.
BioLineRx In-Licenses a Novel, Phase II Ready Drug for the Treatment of Leukemia and Other Hematological Cancers
NEW YORK -- Bioenvision (Nasdaq: BIVN) today announced interim results from the ongoing clinical studies of clofarabine in pediatric and adult acute leukemia trials which confirm clofarabine's outstanding profile observed in previous studies.
Clofarabine's Excellent Results Confirmed at 6th International Symposium on Leukemia and Lymphoma; Latest Results from Adult and Pediatric Acute Leukemia Studies
NEW YORK -- Bioenvision (Nasdaq: BIVN) announced today that an update of clinical data from continuing trials of clofarabine in pediatric and adult acute leukemia will be presented at the 6th International Symposium and Expert Workshop on Leukemia and Lymphoma in Amsterdam on March 17th-19th.
Bioenvision to Report Important Clofarabine Clinical Update and to Host Conference Call on March 21, 2005
Anderson), Houston, reported the latest data from ongoing pediatric and adult acute leukemia clinical trials.
Clinical Data for Bioenvision's Clofarabine Presented at the 8th Congress of the European Haematology Association
Amex:BIV) today announced that it has extended its exclusive, irrevocable option, subject to certain conditions, to manufacture, market and distribute clofarabine, Bioenvision's lead drug for the treatment of pediatric and adult acute leukemias, in Japan and South East Asia.
Bioenvision Extends Exclusive Option to Market Clofarabine in Japan and Southeast Asia
Thesaurus browser ?
Full browser ?